CFTR modulator therapy alters plasma sphingolipid profiles in people with cystic fibrosis.
Westhölter D, Schumacher F, Wülfinghoff N, Sutharsan S, Strassburg S, Kleuser B, Horn PA, Reuter S, Gulbins E, Taube C, Welsner M.
Westhölter D, et al. Among authors: horn pa.
J Cyst Fibros. 2022 Jul;21(4):713-720. doi: 10.1016/j.jcf.2022.02.005. Epub 2022 Feb 12.
J Cyst Fibros. 2022.
PMID: 35168870